PROGRESS Proteolysis , Fibrinolysis , and Coagulation Significance in Thrombolytic Therapy By

[1]  P. W. Boyles.  Laboratory Procedures and Therapy in Coronary Thrombosis , 1961 .

[2]  J. B. Fishman,et al.  Clinical pharmacology of various types of fibrinolytic enzyme preparations , 1960 .

[3]  E. Cliffton.  Review of clinical experience with clotlysing agents. , 1960, The American journal of cardiology.

[4]  A. Sjoerdsma,et al.  Antifibrinolytic activity and metabolism of 6-aminocaproic acid in man. , 1960, Lancet.

[5]  L. Pechet,et al.  Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart). , 1960, Blood.

[6]  B. Alexander,et al.  Preparation and properties of prothrombin. , 1959, The Journal of biological chemistry.

[7]  M. Weiner,et al.  Influence of Some Vasoactive Drugs on Fibrinolytic Activity , 1959, Circulation.

[8]  J. Hagan,et al.  Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid. , 1959, Archives of biochemistry and biophysics.

[9]  A. Fletcher,et al.  xi-Aminocaproic acid: an inhibitor of plasminogen activation. , 1959, The Journal of biological chemistry.

[10]  C. Schneider.  ETIOLOGY OF FIBRINOPENIA: FIBRINATION DEFIBRINATION * , 1959, Annals of the New York Academy of Sciences.

[11]  S. Cohen,et al.  Fibrinolysis; report of a case and clinical review. , 1958, The New England journal of medicine.

[12]  F. Duckert,et al.  The Stuart-Prower Factor Assay and its Clinical Significance , 1958, Thrombosis and Haemostasis.

[13]  I. F. Duff,et al.  Effects of intravenous human plasmin on the blood clotting mechanism of the dog. , 1958, The Journal of laboratory and clinical medicine.

[14]  D. Therriault,et al.  Influence of Thrombin on Rate of Prothrombin Conversion , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[15]  Schneider Cl.  Obstetric shock; some interdependent problems of coagulation. , 1954 .

[16]  C. C. Roby,et al.  Intravascular clotting and afibrinogenemia, the presumptive lethal factors in the syndrome of amniotic fluid embolism. , 1953, American journal of obstetrics and gynecology.

[17]  P. Owren.  Prothrombin and accessory factors; clinical significance. , 1953, The American journal of medicine.

[18]  A. S. Douglas,et al.  The Thromboplastin Generation Test , 1953, Journal of clinical pathology.

[19]  W. Kocholaty,et al.  Activation of plasminogen by trypsin and plasmin. , 1952, Blood.

[20]  Claire Wilson,et al.  Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. , 1951, The Journal of clinical investigation.